Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Use of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to … Pending

2025-520868-17-00 Cancer on the prostatic bed 5
A multicenter, multicohort, phase 2 platform trial to personalize second-line treatment intensity and targeting in HR-positive, HER2-negativ… Pending

2025-523460-21-00 Metastatic breast cancer 4
A trial to learn how safe AZD9793 is, how it moves throughout the body over time, how it affects the body, and how well it works in adults w… Pending

2024-516698-56-00 Hepatocellular Carcinoma 7
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or… Pending

2025-523461-17-01 LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANC 5
A Phase II, Open-Label Randomized Study of Intravenous Tambiciclib in Combination with the Standard of care Venetoclax and Azacitidine in Pa… Pending

2025-524308-31-00 Acute myeloid leukemia 4
A First In Human Phase I Trial Evaluating safety, tolErability and ResponSe of [211At]At-Girentuximab (ATO-101™) in PatiEnts with Non-Muscle… Pending

2023-509729-33-00 Non-Muscle-Invasive Bladder Cancer (NMIBC) refractory 1
LUMC-BOB1-B7-TCR.1 in relapsed and refractory B-cell malignancies Pending

2024-515900-38-00 B-cell Acute Lymphoblastic Leukemia 7
Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastase… Pending

2024-517149-15-00 Rectal cancer 6
CHEMOKINE RECEPTOR CXCR4-DIRECTED THERANOSTICS OF ADVANCED LYMPHOPROLIFERATIVE CANCERS BY RADIOPEPTIDE-BASED IMAGING AND THERAPY: THE COLPRI… Pending

2024-517639-35-00 Non-Hodgkin lymphomas (NHL) 9
uPAR PET/MRI in glioma Pending

2024-519723-20-01 Glioma 9
A Study of S241656 in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies Pending

2025-523474-16-00 Malignancies with Documented KRAS, BRAF and Other Selec 7
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase… Pending

2024-517152-34-00 Irresectable peritoneal metastases of colorectal cancer 4
A Biomarker-Directed, Multi-Centre Phase II/III Study of ctDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer - BR.36 Pending

2025-522084-15-00 metastatic NSCLC patients 10
A study to investigate WEF-001 in patients with Advanced KRAS-Mutant Solid Tumours. Pending

2024-518644-21-01 Advanced KRAS- Mutant Solid Tumours 9
Ironstomach Pending

2024-519738-21-01 Patients with gastric cancer 6
MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Pending

2025-522710-22-00 Cancer, bone metastasis, pain 6
A Phase 2, Open-Label, Single-Arm, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix … Pending

2023-509255-14-01 Advanced prostate cancer 4
Nivolumab dose optimization in patients with a complete, partial or stable response (NIVOPTIMIZE-trial) Pending

2024-516718-39-00 Melanoma 6
Colonic Intramural Injections of Botulin toxin versus placebo to treat fragmented defecation and urgency after restorative total mesorectal … Pending

2025-524342-96-00 Rectal Cancer 4
A study evaluating the safety, tolerability, pharmacokinetics, and activity of RO7566802 given alone and in combination with atezolizumab in… Pending

2023-509266-38-00 Locally Advanced or Metastatic Solid Tumors 1
Receptor radionuclide therapy with 177Lu-DOTATOC (177Lu- edotreotide or 177Lu-octreotide) in SSTR positive patients: a multicenter, prospect… Pending

2024-519183-40-00 NET 4
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorect… Pending

2025-523521-18-00 Metastatic Colorectal Cancer 5
OV-PRIME-R (Oncolytic Virotherapy to enhance PReoperative IMmunotherapy Efficacy in patients with proficient mismatch repair (pMMR) Rectal c… Pending

2025-524375-23-00 Rectal cancer with proficient mismatch repair (pMMR) 3
Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas Pending

2024-520318-23-00 Patients with advanced soft-tissue sarcoma (leiomyosarc 9